Telemonitoring and Quality of Life in Patients after 12 Months Following a Pacemaker Implant: the Nordland Study, a Randomised Trial

Remedios López-Liria, Antonio López-Villegas, Terje Enebakk, Hilde Thunhaug, Knut Tore Lappegård, Daniel Catalán-Matamoros, Remedios López-Liria, Antonio López-Villegas, Terje Enebakk, Hilde Thunhaug, Knut Tore Lappegård, Daniel Catalán-Matamoros

Abstract

The purpose of this study was to analyse the health-related quality of life (HRQoL) of patients followed up using a remote device-monitoring system (TM) compared to patients followed up through standard outpatient visits (HM), 12 months after the implantation of a pacemaker. This was a trial design that used the EuroQol-5D Questionnaire and the Minnesota Living with Heart Failure Questionnaire (MLHF). The HRQoL of a cohort of 50 consecutive patients randomly allocated to one of the two follow-up modalities was measured at baseline and then during follow-up, 12 months after the pacemaker implantation. Eventually, 23 patients were followed-up through standard outpatient visits, while 23 used a remote monitoring system. Results: The baseline clinical characteristics and health-related quality of life of the patients from both groups were observed to be statistically similar. Twelve months after the pacemaker implantation, both groups showed statistically significant improvements in the baseline parameters based on the MLHF. The patients followed up through hospital visits showed a greater increase in MLHF-HRQoL after 12 months, although the increase was not significantly greater than that of the TM group. Furthermore, the frequencies of emergency visits and re-hospitalisations did not differ between the groups.

Trial registration: ClinicalTrials.gov NCT02237404.

Keywords: long term; pacemaker follow-up; quality of life; remote monitoring; telemedicine.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow (CONSORT) diagram of the study.

References

    1. Okamura H. Remote monitoring of cardiovascular implantable electronic devices in Japan. J. Arrhythmia. 2014;30:421–427. doi: 10.1016/j.joa.2014.04.012.
    1. Ellenbogen K.A., Freedman R.A., Gettes L.S., Gillinov A.M., Gregoratos G., Hayes D.L., Hlatky M.A., Newby L.K., Page R.L., Sweeney M.O., et al. 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2012;127:e283–e352.
    1. World Health Organization . Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth. WHO Publications; Geneva, Switzerland: 2010. [(accessed on 18 January 2018)]. Available online: .
    1. Brumley R., Enguidanos S., Jamison P., Seitz R., Morgenstern N., Saito S., McIlwane J., Hillary K., Gonzalez J. Increased Satisfaction with Care and Lower Costs: Results of a Randomized Trial of In-Home Palliative Care. J. Am. Geriatr. Soc. 2007;55:993–1000. doi: 10.1111/j.1532-5415.2007.01234.x.
    1. Inglis S.C., Clark R.A., McAlister F.A., Stewart S., Cleland J.G. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Coc. Eur. J. Hear. Fail. 2011;13:1028–1040. doi: 10.1093/eurjhf/hfr039.
    1. Kotb A., Cameron C., Hsieh S., Wells G. Comparative Effectiveness of Different Forms of Telemedicine for Individuals with Heart Failure (HF): A Systematic Review and Network Meta-Analysis. PLoS ONE. 2015;10:e0118681. doi: 10.1371/journal.pone.0118681.
    1. Knox L., Rahman R.J., Beedie C. Quality of life in patients receiving telemedicine enhanced chronic heart failure disease management: A meta-analysis. J. Telemed. Telecare. 2017;23:639–649. doi: 10.1177/1357633X16660418.
    1. Villani A., Della Rosa F., Bellardita L., Branzi G., Malfatto G., Compare A., Molinari E., Parati G. Clinical and psychological telemonitoring and telecare of high risk heart failure patients. J. Telemed. Telecare. 2014;20:468–475. doi: 10.1177/1357633X14555644.
    1. Seto E. Cost Comparison Between Telemonitoring and Usual Care of Heart Failure: A Systematic Review. Telemed. e-Health. 2008;14:679–686. doi: 10.1089/tmj.2007.0114.
    1. Olen M.M., Dechert-Crooks B. Implantable cardiac devices: The utility of remote monitoring in a paediatric and CHD population. Cardiol. Young. 2017;27:S143–S146. doi: 10.1017/S1047951116002390.
    1. Lim P.C.Y., Lee A.S.Y., Chua K.C.M., Lim E.T.S., Chong D.T.T., Tan B.Y., Ho K.L., Teo W.S., Ching C.K. Remote monitoring of patients with cardiac implantable electronic devices: A Southeast Asian, single-centre pilot study. Singap. Med. J. 2016;57:372–377. doi: 10.11622/smedj.2016120.
    1. Mabo P., Victor F., Bazin P., Ahres S., Babuty D., Da Costa A., Binet D., Daubert J.C. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial) Eur. Heart J. 2012;33:1105–1111. doi: 10.1093/eurheartj/ehr419.
    1. López-Villegas A., Catalán-Matamoros D., Robles-Musso E., Peiró S. Comparative effectiveness of remote monitoring of people with cardiac Pacemaker versus conventional: Quality of life at the six months. Rev. Esp. Salud Publica. 2015;89:149–158. doi: 10.4321/S1135-57272015000200004.
    1. López-Villegas A., Catalán-Matamoros D., Robles-Musso E., Peiro S. Effectiveness of pacemaker tele-monitoring on quality of life, functional capacity, event detection and workload: The PONIENTE trial. Geriatr. Gerontol. Int. 2016;16:1188–1195. doi: 10.1111/ggi.12612.
    1. Hole T., Grundtvig M., Gullestad L., Flønaes B., Westheim A., Flønæs B. Improved quality of life in Norwegian heart failure patients after follow-up in outpatient heart failure clinics: Results from the Norwegian heart failure registry. Eur. J. Hear. Fail. 2010;12:1247–1252. doi: 10.1093/eurjhf/hfq156.
    1. Dar O., Riley J., Chapman C., Dubrey S.W., Morris S., Rosen S.D., Roughton M., Cowie M.R. A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: Results of the Home-HF study. Eur. J. Hear. Fail. 2009;11:319–325. doi: 10.1093/eurjhf/hfn050.
    1. Ong M.K., Romano P.S., Edgington S., Aronow H.U., Auerbach A.D., Black J.T., De Marco T., Escarce J.J., Evangelista L.S., Hanna B., et al. Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients with Heart Failure: The Better Effectiveness After Transition–Heart Failure (BEAT-HF) Randomized Clinical Trial. JAMA Intern. Med. 2016;176:310–318. doi: 10.1001/jamainternmed.2015.7712.
    1. Lopez-Villegas A., Catalan-Matamoros D., Lopez-Liria R., Enebakk T., Thunhaug H., Lappegård K.T. Health-related quality of life on tele-monitoring for users with pacemakers 6 months after implant: The NORDLAND study, a randomized trial. BMC Geriatr. 2018;18:223. doi: 10.1186/s12877-018-0911-3.
    1. EuroQol Group EuroQol A new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9.
    1. Rector T.S., Kubo S.H., Cohn J.N. Patients self-assessment of their congestive heart failure: Content, reliability and validity of a new measure, The Minnesota Living with Heart Failure questionnaire. Heart Failure. 1987;3:198–209.
    1. Bharmal M., Thomas J., Bharmal D.M. Comparing the EQ-5D and the SF-6D Descriptive Systems to Assess Their Ceiling Effects in the US General Population. Value Heal. 2006;9:262–271. doi: 10.1111/j.1524-4733.2006.00108.x.
    1. Balestroni G., Bertolotti G. EuroQol-5D (EQ-5D): An instrument for measuring quality of life. Monaldi Arch. Chest Dis. 2012;78:155–159. doi: 10.4081/monaldi.2012.121.
    1. Savoia E., Fantini M.P., Pandolfi P.P., Dallolio L., Collina N. Assessing the construct validity of the Italian version of the EQ-5D: Preliminary results from a cross-sectional study in North Italy. Heal. Qual. Life Outcomes. 2006;4:47. doi: 10.1186/1477-7525-4-47.
    1. Morgan K., McGee H., Shelley E. Quality of life assessment in heart failure interventions: A 10-year (1996–2005) review. Eur. J. Cardiovasc. Prev. Rehabil. 2007;14:589–607. doi: 10.1097/HJR.0b013e32828622c3.
    1. Ricci R.P., Vicentini A., D’Onofrio A., Sagone A., Rovaris G., Padeletti L., Morichelli L., Fusco A., De Vivo S., Lombardi L., et al. Economic analysis of remote monitoring of cardiac implantable electronic devices: Results of the Health Economics Evaluation Registry for Remote Follow-up (TARIFF) study. Hear. Rhythm. 2017;14:50–57. doi: 10.1016/j.hrthm.2016.09.008.
    1. Comoretto R.I., Facchin D., Ghidina M., Proclemer A., Gregori D. Remote control improves quality of life in elderly pacemaker patients versus standard ambulatory-based follow-up. J. Eval. Clin. Pract. 2017;23:681–689. doi: 10.1111/jep.12691.
    1. Antonicelli R., Testarmata P., Spazzafumo L., Gagliardi C., Valentini M., Olivieri F., Bilo G., Parati G. Impact of telemonitoring at home on the management of elderly patients with congestive heart failure. J. Telemed. Telecare. 2008;14:300–305. doi: 10.1258/jtt.2008.071213.
    1. Klersy C., De Silvestri A., Gabutti G., Regoli F., Auricchio A. A Meta-Analysis of Remote Monitoring of Heart Failure Patients. J. Am. Coll. Cardiol. 2009;54:1683–1694. doi: 10.1016/j.jacc.2009.08.017.
    1. López-Villegas A., Catalán-Matamoros D., Martín-Saborido C., Villegas-Tripiana I., Robles-Musso E. A Systematic Review of Economic Evaluations of Pacemaker Telemonitoring Systems. Rev. Esp. Cardiol. 2016;69:125–133. doi: 10.1016/j.recesp.2015.06.021.
    1. Slotwiner D., Varma N., Akar J.G., Annas G., Beardsall M., Fogel R.I., Galizio N.O., Glotzer T.V., Leahy R.A., Love C.J., et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Hear. Rhythm. 2015;12:e69–e100. doi: 10.1016/j.hrthm.2015.05.008.
    1. López-Villegas A., Catalán-Matamoros D., Robles-Musso E., Peiró S. Workload, time and costs of the informal cares in patients with tele-monitoring of pacemakers: The PONIENTE study. Clin. Res. Cardiol. 2016;105:307–313. doi: 10.1007/s00392-015-0921-5.
    1. Madigan E., Schmotzer B.J., Struk C.J., Dicarlo C.M., Kikano G., Piña I.L., Boxer R.S. Home Health Care with Telemonitoring Improves Health Status for Older Adults with Heart Failure. Home Health Care Serv. Q. 2013;32:57–74. doi: 10.1080/01621424.2012.755144.
    1. Varma N., Michalski J., Stambler B., Pavri B.B. TRUST Investigators Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial-testing execution of the recommendations. Eur. Hear. J. 2014;35:1345–1352. doi: 10.1093/eurheartj/ehu066.
    1. Spleen A.M., Lengerich E.J., Camacho F.T., Vanderpool R.C. Health care avoidance among rural populations: Results from a nationally representative survey. J. Rural Health. 2014;30:79–88. doi: 10.1111/jrh.12032.
    1. Field K.S., Briggs D.J. Socio-economic and locational determinants of accessibility and utilization of primary health-care. Health Soc. Care Community. 2001;9:294–308. doi: 10.1046/j.0966-0410.2001.00303.x.
    1. Leahy R.A., Davenport E.E. Home Monitoring for Cardiovascular Implantable Electronic Devices: Benefits to Patients and to Their Follow-up Clinic. AACN Adv. Crit Care. 2015;26:343–355. doi: 10.1097/NCI.0000000000000110.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir